Clomifene
- Generic Name
- Clomifene
- Brand Names
- Clomid
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28ClNO
- CAS Number
- 911-45-5
- Unique Ingredient Identifier
- 1HRS458QU2
- Background
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.
- Indication
Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
- Associated Conditions
- Ovulatory Dysfunction
Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 210
- Registration Number
- NCT02690870
The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene
Phase 2
Completed
- Conditions
- Anovulatory
- Interventions
- First Posted Date
- 2016-01-26
- Last Posted Date
- 2017-08-16
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 210
- Registration Number
- NCT02663830
A Comparison of Letrozole and Clomifene Citrate
Not Applicable
- Conditions
- SubfertilityPolycystic Ovarian Syndrome
- Interventions
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 40
- Registration Number
- NCT02647424
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome
Phase 2
- Conditions
- Female Reproductive Problem
- Interventions
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Woman's Health University Hospital, Egypt
- Target Recruit Count
- 88
- Registration Number
- NCT02644304
- Locations
- 🇪🇬
Assiut university, Assiut, Egypt
Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI
- First Posted Date
- 2015-12-23
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 86
- Registration Number
- NCT02638285
- Locations
- 🇮🇷
Health Policy Research Center, Shiraz, Fars, Iran, Islamic Republic of
Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 2 With and Without Suppression by Dienogest
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 310
- Registration Number
- NCT02575248
- Locations
- 🇪🇬
AinShamsU, Abbasia, C, Egypt
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
Phase 2
- Conditions
- AnovulationPolycystic Ovary Syndrome
- Interventions
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- mostafa gomaa hamid halawa
- Target Recruit Count
- 110
- Registration Number
- NCT02551367
Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients
Not Applicable
Completed
- Conditions
- Female Infertility Associated With Anovulation
- Interventions
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- Ahmed Fathy Ali Mohamed Ghanem
- Target Recruit Count
- 60
- Registration Number
- NCT02544776
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Phase 2
Terminated
- Conditions
- HyperandrogenismPolycystic Ovary Syndrome
- Interventions
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Semnan University of Medical Sciences
- Target Recruit Count
- 388
- Registration Number
- NCT02523898
SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis
Not Applicable
Withdrawn
- Conditions
- InfertilityEndometriosis
- Interventions
- Behavioral: Timed intercourseProcedure: Intrauterine Insemination
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- The Cleveland Clinic
- Registration Number
- NCT02520505
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath